Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
1255 daily bars · split adjusted
Daily · Wilder smoothing
Annual filings (FY) with consensus forward estimates (hatched)
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 39.26 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 27.09 | Oscillator | Neutral |
| Williams %R (14) | -64.00 | Oscillator | Neutral |
| MACD (12, 26, 9) | -0.94 (Hist 0.06) | Oscillator | Buy |
| Average Directional Index (14) | 30.61 (+DI 11.6 / -DI 26.1) | Trend | Strong Sell |
| EMA 20 | 21.29 | MA | Strong Sell |
| SMA 20 | 21.13 | MA | Strong Sell |
| EMA 50 | 23.24 | MA | Strong Sell |
| SMA 50 | 23.67 | MA | Strong Sell |
| SMA 200 | 28.98 | MA | Strong Sell |
Current price $20.39
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Oct 19, 26 | Stifel | maintain | Buy | Buy |
| Jul 20, 26 | Stifel | maintain | Buy | Buy |
| Apr 14, 26 | Stifel | maintain | Buy | Buy |
| Feb 18, 26 | Freedom Broker | maintain | Buy | Buy |
| Feb 18, 26 | Citigroup | maintain | Neutral | Neutral |
| Dec 16, 25 | Stifel | maintain | Buy | Buy |
| Dec 15, 25 | Citigroup | maintain | Neutral | Neutral |
| Oct 20, 25 | Stifel | maintain | Buy | Buy |
| Feb 18, 22 | Benchmark | downgrade | Buy | Hold |
TTM vs. 5-year historical average (annual ratios)
| Metric | CPS | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -6.5x | -29.9x · sector 73.6x | Discount |
| Forward P/E (FY26E) | 14.1x | EPS est. 1.45 | Discount |
| Price / Book | -0.0x | -2.1x | Discount |
| Price / Sales | 0.1x | 0.1x | In line |
| EV / EBITDA | 7300.8x | 456.9x | Elevated |
| Return on equity | 0.2% | — | Weak |
| Gross margin | 11.3% | 8.4% | Above hist. |
| Debt / Equity | -9.15 | -4.86 | Conservative |
| Piotroski / Altman Z | 2/9 | Z -0.24 | Distress |
Discounted cash flow model
Stock news · updated daily
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (NASDAQ: MRNA) today announced detailed positive recurrence-free surv
NORTHVILLE, Mich., Oct. 21, 2026 /PRNewswire/ -- Cooper-Standard Holdings Inc. (NYSE: CPS) expects to release its financial results for the third quarter 2026 on Wednesday, Nov. 4 after market close.
Denso (OTCMKTS:DNZOY - Get Free Report) and Cooper-Standard (NYSE: CPS - Get Free Report) are both consumer discretionary companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation and analyst recommendations. Institutional and Insider Ownership 69.1% of Cooper-Standard shares are
NORTHVILLE, Mich., Sept. 24, 2026 /PRNewswire/ -- Cooper Standard (NYSE: CPS) today announced the appointment of Matthew Boddy as senior vice president, chief commercial officer.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Medicines Agency's Committee for Medicinal Products for Hu
[url="]Elastic[/url] (NYSE: ESTC) today announced the general availability of cross-project search (CPS) for Elastic Cloud Serverless, enabling teams to query a
NORTHVILLE, Mich., Sept. 10, 2026 /PRNewswire/ -- Cooper Standard's (NYSE: CPS) El Jarudo manufacturing facility in Juárez, Chihuahua, Mexico, has earned recognition for manufacturing excellence as one of four winners of IndustryWeek's 2026 Best Plants Awards.
NORTHVILLE, Mich., Sept. 2, 2026 /PRNewswire/ -- Cooper Standard (NYSE: CPS), a leading global supplier of sealing and fluid handling systems and components, today announced that the Science-Based Targets initiative (SBTi) has validated Cooper Standard's near-term science-based emissions reduction targets.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | 0.54 | -0.13 | Miss -123.9% | $721.3M |
| May 6, 2026 | -0.16 | -0.29 | Miss -81.2% | $686.4M |
| Feb 12, 2026 | -0.95 | -1.73 | Miss -82.1% | $672.4M |
| Oct 30, 2025 | 0.50 | -0.24 | Miss -148.0% | $695.5M |
| Jul 31, 2025 | -0.59 | 0.06 | Beat 110.2% | $706.0M |
| May 1, 2025 | -0.58 | 0.19 | Beat 132.8% | $667.1M |
FY2025 · 10-K disclosure
FY2025 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 28, 26 | Boddy Matthew W. | officer: SVP, Chief Commerical Officer | A-Award | 4,473 | — |
| 4 | Aug 11, 2026 | 2026-08-11 07:49:46 | View |
| 10-Q | Aug 6, 2026 | 2026-08-06 16:03:53 | View |
| 8-K | Aug 6, 2026 | 2026-08-06 07:02:54 | View |
| 4 | Aug 5, 2026 | 2026-08-05 07:54:37 | View |
| 4 | May 18, 2026 | 2026-05-18 16:55:14 | View |
| 4 | May 18, 2026 | 2026-05-18 16:55:09 | View |
Proxy statement (DEF 14A) disclosures
| Sep 28, 26 |
| Boddy Matthew W. |
| officer |
| 0 |
| — |
| Sep 15, 26 | Venkatasubramanian Somasundhar | officer: See remarks | M-Exempt | 300 | — |
| Sep 15, 26 | Venkatasubramanian Somasundhar | officer: See remarks | F-InKind | 86 @ $23.08 | $1.98K |
| Sep 15, 26 | Venkatasubramanian Somasundhar | officer: See remarks | M-Exempt | 300 | — |
| Aug 7, 26 | Kanary Maryann Peterson | officer: See remarks | M-Exempt | 3,619 | — |
| Aug 7, 26 | Kanary Maryann Peterson | officer: See remarks | F-InKind | 1,578 @ $31.40 | $49.55K |
| Aug 7, 26 | Kanary Maryann Peterson | officer: See remarks | M-Exempt | 3,619 | — |